Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome
This clinical trial update describes cascade genetic testing in families with newly diagnosed hereditary breast and ovarian cancer syndrome.…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Cognitive Training and Exercise for Women With Breast Cancer and Cognitive Impairment [NA]
A clinical trial evaluating cognitive training and exercise for women with breast cancer and cognitive impairment; currently not recruiting.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Real-world clinical trial update on sacituzumab govitecan as monotherapy or in combination for recurrent or metastatic HER2-negative breast …
-
CLINICAL_TRIALS other · 2025-06-12Clinical Trial Update: Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
A clinical trial examining magnetic resonance imaging in radiotherapy for breast cancer (NCT05902507) has been suspended. The sponsor is Uni…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation Therapy
A completed clinical trial evaluating cardiac MRI for assessing cardiac effects in patients with left-sided breast cancer undergoing radiati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Early Intervention [NA]
A clinical trial update from Massachusetts General Hospital on early intervention for breast cancer and its treatment-related lymphedema. Th…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Effect of a Fruit- and Chaya-Based Diet on Genomic Instability and Biochemical Markers in Women With Breast Cancer Receiving Chemotherapy [NA]
Clinical trial update on a fruit- and chaya-based diet and its impact on genomic instability and biochemical markers in women with breast ca…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating a triple therapy of Pyrotinib, Dalpiciclib, and Letrozole for ER-positive, HER2-positive advanced bre…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating safety and efficacy of an antibody linked to chemotherapy for triple-negative metastatic breast cancer; trial is cu…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Early Diagnosis of Breast Cancer-related Lymphedema
This update describes a clinical trial investigating early diagnosis of breast cancer–related lymphedema. It is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery
ClinicalTrials.gov entry for a study on glutamate excitotoxicity in brain metastases from lung cancer, breast cancer, and melanoma treated w…
-
EMA approval · 2025-06-10EMA Authorised: Apexelsin (paclitaxel) — Whiteoak Pharmaceutical B.V.
The EMA authorised Apexelsin (paclitaxel) for breast cancer, pancreatic cancer, and non-small cell lung cancer, with Whiteoak Pharmaceutical…
-
FDA approval · 2025-06-10FDA Approved: EXEMESTANE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Exemestane from Zydus Pharmaceuticals USA Inc., updating an existing approved product.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer [Phase 2]
A Phase 2 neoadjuvant study is evaluating olaparib alone and in combination with durvalumab in HER2-negative, BRCA-mutated breast cancer; th…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors [NA]
A completed clinical trial from Michigan State University evaluated whether bright light therapy reduces co-occurring cancer-related symptom…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer [Phase 3]
A Phase 3 trial compares HLX11 to EU-Perjeta (pertuzumab) as neoadjuvant therapy for HER2-positive, hormone receptor-negative breast cancer.…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours [Phase 3]
This entry describes the Add-Aspirin Phase 3 trial evaluating whether adding aspirin after primary therapy reduces recurrence and improves s…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant Therapy
This update describes the rationale and study design for the PFB-03 trial evaluating 18F-FAPI-PET/CT for detecting axillary lymph node metas…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer [NA]
This clinical trial update outlines ongoing research into the mechanisms that explain differences in efficacy among neoadjuvant regimens for…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Adaptive Therapy for Post-Second-Line Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating adaptive therapy for post-second-line HER2-negative metastatic breast cancer has completed.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction [NA]
A clinical trial update from Washington University School of Medicine on using AI-assisted consultations (ChatGPT) to support breast reconst…
-
FDA approval · 2025-06-09FDA Approved: ERIBULIN MESYLATE — Original Application (Sandoz Inc)
The FDA approved Sandoz's original ANDA for ERIBULIN MESYLATE, authorizing the generic product's marketing in the United States.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment [Phase 2]
Phase 2 trial of eribulin monotherapy as first-line treatment for HER2-negative metastatic breast cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer [Phase 1]
Phase 1 trial evaluating whether combining a ketogenic diet with chemotherapy can affect recurrence in patients with stage IV breast cancer;…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Assessment of Paclitaxel-Induced Neuropathy
This clinical trial update concerns assessment of paclitaxel-induced neuropathy in cancer patients, including breast and ovarian cancer, and…